Konferenzen zum Thema Hämatologie in den Vereinigten Staaten (USA)

Wählen Sie ein Land aus
GW Hematology Update 2019 Live Webcast and Webinar
23. Feb 2019 - 22. Feb 2020 • Virtual, Vereinigte Staaten
Recorded at the GW Hematology Update 2019 Live Event, which will take place on February 23, 2019, this one-day program, presented on behalf of the GW Cancer Center, provides an extensive update of the latest diagnostic and therapeutic advances in the field of hematology. A panel of leading experts will present cutting-edge research, new guidelines, and recent abstracts from major hematology meetings. Hematology Update also offers practical strategies to help incorporate these advances into daily clinical practice.
Tel.: [(646) 887-2650];     Email: meetings@sanovaworks.com
Hematology, CME, Education, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, GW Cancer Center
SOHO 2019 — Annual Meeting
11. Sep 2019 - 14. Sep 2019 • Houston, Texas, Vereinigte Staaten
Society of Hematologic Oncology
Verwandte Fachgebiete:
Novel Discoveries in Cancer Research & Treatment — 2019 Cancer Research & Therapy
14. Okt 2019 - 16. Okt 2019 • FL,Orlando, Vereinigte Staaten
Tel.: [408-352-1010];     Email: info@2019crtc.com
Cancer Biomarkers 2 Cancer Gene Therapy 3 Cancer Nursing 4 Clinical Oncology 5 Pediatric Oncology 6 Radiation, Surgical and Medical oncology 7 Cancer Genetics 8 Breast Cancer Research 9 Cancer Stem Cell Therapy 10 Innovations in prevention and screening 11 Anti-Cancer Drug Discovery & Therapy 12 Cancer Screening & Diagnosis 13 Cancer Immunology & Vaccines 14 Organ Specific Cancers and Effects
Verwandte Fachgebiete:
MPN Congress — 12th International Congress on Myeloproliferative Neoplasms
24. Okt 2019 - 25. Okt 2019 • New York City, Vereinigte Staaten
Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, the Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders. The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis and management, as well as the roles of next generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed. New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning. The program features a world class faculty and highly interactive sessions designed to engage participants and provide a state-of-the-art learning experience.
Tel.: [512-619-5534];     Email: info@meltonmeded.com
myeloproliferative neoplasms, MPN, polycythemia vera, PV, essential thrombocythemia, ET, myelofibrosis, MF, PMF, Chronic myeloid leukemia, CML, CNL, mastocytosis, hematopoiesis
American Society of Hematology 61st Annual Meeting 2019
07. Dez 2019 - 10. Dez 2019 • Orlando, Vereinigte Staaten
Mayo Clinic Clinical and Multidisciplinary Hematology and Oncology 2020: The 17th Annual Review 2020
07. Feb 2020 - 09. Feb 2020 • Scottsdale, Vereinigte Staaten
Scripps’ 40th Annual Conference: Clinical Hematology & Oncology 2020
15. Feb 2020 - 18. Feb 2020 • San Diego, Vereinigte Staaten
ASH Meeting on Lymphoma Biology 2020
06. Aug 2020 - 09. Aug 2020 • Chantilly, Vereinigte Staaten

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Stand vom 17. August 2019